To continue or discontinue aspirin? The risk of perioperative complications
Keywords
aspirin, acetylsalicylic acid, complicationsAbstract
Acetylsalicylic acid (aspirin) is a noncompetitive irreversible antagonist of the enzyme cyclooxygenase 1 (COX1). This drug is commonly used in prevention of cardiovascular and cerebrovascular events due to inhibition of platelet function. Because of the risk of surgical hemorrhage it is recommended to cessation aspirin intake couple days before the surgical intervention. However, discontinuation of aspirin treatment may results in increased risk of thrombotic events and perioperative complications. Antithrombotic Trialist's Collaboration proved that low dose of aspirin intake before surgery reduces the risk of nonfatal myocardial infarction by 33%, vascular events by 17% and nonfatal stroke by 25%. However, some studies showed the increased risk of perioperative bleeding in patients continuing aspirin treatment. The position of experts is not unambiguous and there have been doubts about the necessity of discontinuation or continuation this drug before surgery.Downloads
Published
2018-08-19
How to Cite
1.
MROCZEK, Anna, BAŁABUSZEK, Kamil, RADZKA, Agnieszka, FAŁKOWSKA, Urszula, PAWLICKA, Marta and BEDNARSKI, Jerzy. To continue or discontinue aspirin? The risk of perioperative complications. Journal of Education, Health and Sport. Online. 19 August 2018. Vol. 8, no. 8, pp. 743-747. [Accessed 16 August 2024].
Issue
Section
Review Articles
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 392
Number of citations: 0